Market News & Analysis


Market Brief: Indices Cap Off Fourth Straight Up Week in Record Territory


View our guide on how to interpret the FX Dashboard.

  • President Trump floated a “major” middle class income cut, though the market is skeptical about such a deal getting done. Speaking of deals getting done, optimistic comments from economic adviser Kudlow boosted risk appetite across the board today.
  • FX: The risk-sensitive Australian and New Zealand dollars were the strongest major currencies, with safe haven currencies like the Japanese yen and Swiss franc bringing up the rear. The pound caught a bid after Brexit party candidates vowed to stand down in over 40 districts.
  • US data: US retail sales beat expectations at +0.3% m/m, though “core” retail sales (excluding volatile auto purchases) came in below expectations at +0.2% m/m.
  • Commodities: Oil rallied nearly 2% on the day (a surprise drop in oil rigs certainly helped) while gold eased back about 0.5%.
 
  • US indices closed solidly higher on the day to hit fresh record highs.
  • Health Care stocks (XLV) were by far the strongest sector on the day, while Materials (XLB) brought up the rear.
  • See the key storylines and trends we’ll be watching in the coming week!
  • Stocks on the move:
    • Nvidia (NVDA) shed -3% on a weaker-than-expected outlook, even though the company’s Q3 earnings eclipsed analysts’ expectations.
    • WalMart (WMT) dipped -1% after missing revenue forecasts, though the company’s key online business grew 41%.
    • Applied Materials (AMAT) surged 9% after beating both earnings and revenue estimates.
    • Chinese retailer JD.com (JD, -0%) was essentially flat on the day despite easily beating analysts’ earnings estimates. The stock is up nearly 70% year-to-date.

* No major economic releases are scheduled for Monday’s Asian session*


From time to time, GAIN Capital Australia Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.

As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.